Liraglutide
SCALE™ Insulin
Novo Nordisk · Phase 3 · Completed · Enrollment 396
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| liraglutide 3.0 mg | 58 participants | 32 participants | 45 participants | n/r | 0 |
| Placebo | 23 participants | 12 participants | 30 participants | n/r | 0 |
A count stays a count. This page does not turn a count into a percent.